Morgan Stanley Omega Therapeutics, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 28,572 shares of OMGA stock, worth $285. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,572

Previous 43,983 35.04%

Holding current value

$285

Previous $53,000 60.38%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.75 - $1.45 $11,558 - $22,345	-15,411 Reduced 35.04%	28,572 $21,000
Q3 2024 Nov 14, 2024	SELL	$1.22 - $2.25 $61,019 - $112,536	-50,016 Reduced 53.21%	43,983 $53,000
Q2 2024 Oct 17, 2024	SELL	$1.86 - $3.2 $64,289 - $110,604	-34,564 Reduced 26.88%	93,999 $194,000
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.2 $64,289 - $110,604	-34,564 Reduced 26.88%	93,999 $194,000
Q1 2024 Oct 17, 2024	BUY	$2.73 - $5.32 $94,359 - $183,880	34,564 Added 36.77%	128,563 $469,000
Q1 2024 Aug 16, 2024	BUY	$2.73 - $5.32 $102,910 - $200,542	37,696 Added 41.48%	128,563 $469,000
Q1 2024 May 15, 2024	BUY	$2.73 - $5.32 $102,910 - $200,542	37,696 Added 41.48%	128,563 $469,000
Q4 2023 Aug 16, 2024	SELL	$1.35 - $3.21 $4,228 - $10,053	-3,132 Reduced 3.33%	90,867 $273,000
Q4 2023 Feb 13, 2024	BUY	$1.35 - $3.21 $10,212 - $24,283	7,565 Added 9.08%	90,867 $273,000
Q3 2023 Nov 15, 2023	BUY	$2.15 - $5.68 $11,668 - $30,825	5,427 Added 6.97%	83,302 $179,000
Q2 2023 Aug 14, 2023	BUY	$5.6 - $9.66 $32,177 - $55,506	5,746 Added 7.97%	77,875 $436,000
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $197,541 - $449,705	41,069 Added 132.22%	72,129 $434,000
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $55,357 - $92,481	13,118 Added 73.11%	31,060 $177,000
Q3 2022 Nov 14, 2022	SELL	$3.63 - $6.65 $50,446 - $92,415	-13,897 Reduced 43.65%	17,942 $98,000
Q2 2022 Oct 27, 2022	BUY	$2.01 - $7.19 $29,842 - $106,749	14,847 Added 87.38%	31,839 $121,000
Q2 2022 Aug 15, 2022	BUY	$2.01 - $7.19 $29,842 - $106,749	14,847 Added 87.38%	31,839 $121,000
Q1 2022 Oct 27, 2022	SELL	$6.24 - $14.04 $92,645 - $208,451	-14,847 Reduced 46.63%	16,992 $106,000
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $44,940 - $101,116	7,202 Added 73.56%	16,992 $106,000
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $106,434 - $275,995	9,394 Added 2372.22%	9,790 $111,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $6,336 - $8,913	396 New	396 $7,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

42.6M

Call Options Held

24.6K

Put Options Held

5.8K

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $479K
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account